2022

Home >> 2022 >> Seite 24
Feature image not available
11.01.2022

Fluorescence lifetime DNA-PAINT for multiplexed super-resolution imaging of cells

Authors Oleksiievets N, Sargsyan Y, Thiele JC, Mougios N, Sograte-Idrissi S, Nevskyi O, Gregor I, Opazo F, Thoms S, Enderlein J, Tsukanov R Journal Communications Biology Citation Commun Biol 5, 38 (2022). Abstract DNA point accumulation for imaging in nanoscale topography (DNA-PAINT) is a powerful super-resolution technique highly suitable for
Learn More
ERC-Starting Grant für Prof. Dr. Ecker

Alexander Ecker erhält ERC-Starting Grant. Foto: privat/ MICrONS Consortium.

11.01.2022

Alexander Ecker erhält ERC-Starting Grant

Das MBExC gratuliert dem Informatiker und Hirnforscher Prof. Dr. Alexander Ecker von der Universität Göttingen und dem Max-Planck-Institut für Dynamik und Selbstorganisation (MPIDS) zum Erhalt eines Starting Grant des Europäischen Forschungsrats (ERC). Der ERC unterstützt damit sein Projekt „Deep Neuron Embeddings: Data-driven multi-modal discovery of cell types in the neocortex“
Learn More
Feature image not available
10.01.2022

The Role of Junctophilin Proteins in Cellular Function

Authors Lehnart SE, Wehrens XHT Journal Physiological Reviews Citation Physiol Rev. 2022 Jan 10. Abstract Junctophilins (JPHs) comprise a family of structural proteins that connect the plasma membrane to intracellular organelles such as the endo/sarcoplasmic reticulum. Tethering of these membrane structures results in the formation of highly organized subcellular junctions
Learn More
Feature image not available
10.01.2022

Recent Advances in Modeling Mitochondrial Cardiomyopathy Using Human Induced Pluripotent Stem Cells

Authors Pavez-Giani MG, Cyganek L Journal Frontiers in Cell and Developmental Biology Citation Front Cell Dev Biol. 2022 Jan 10;9:800529. Abstract   Around one third of patients with mitochondrial disorders develop a kind of cardiomyopathy. In these cases, severity is quite variable ranging from asymptomatic status to severe manifestations including
Learn More
Feature image not available
06.01.2022

Prion-like α-synuclein pathology in the brain of infants with Krabbe disease

Authors Hatton C, Ghanem SS, Koss DJ, Abdi IY, Gibbons E, Guerreiro R, Bras J, International DLB Genetics Consortium, Walker L, Gelpi E, Heywood W, Outeiro TF, Attems J, McFarland R, Forsyth R, El-Agnaf OM, Erskine D Journal Brain Citation Brain. 2022 May 24;145(4):1257-1263. Abstract Krabbe disease is an infantile
Learn More
Feature image not available
04.01.2022

Endogenous Levels of Alpha-Synuclein Modulate Seeding and Aggregation in Cultured Cells

Authors Vasili E, Dominguez-Meijide A, Flores-León M, Al-Azzani M, Kanellidi A, Melki R, Stefanis L, Outeiro TF Journal Molecular Neurobiology Citation Mol Neurobiol. 2022 Jan 4. Abstract Parkinson’s disease is a progressive neurodegenerative disorder characterized by the accumulation of misfolded alpha-synuclein in intraneuronal inclusions known as Lewy bodies and Lewy
Learn More
Feature image not available
04.01.2022

Forces, Kinetics, and Fusion Efficiency Altered by the Full-Length Synaptotagmin‑1 -PI(4,5)P2 Interaction in Constrained Geometries

Authors Dietz J, Oelkers M, Hubrich R, Pérez-Lara A, Jahn R, Steinem C, Janshoff A Journal Nano Letters Citation Nano Lett. 2022, Jan 4 Abstract A mechanism for full-length synaptotagmin-1 (syt-1) to interact with anionic bilayers and to promote fusion in the presence of SNAREs is proposed. Colloidal probe force
Learn More
Feature image not available
04.01.2022

Postnatal expression of the lysine methyltransferase SETD1B is essential for learning and the regulation of neuron‐enriched genes

Authors Michurina A, Sakib S, Kerimoglu C, Krüger DM, Kaurani L, Islam R, Joshi PD, Schröder S, Centeno TP, Zhou J, Pradhan R, Cha J, Xu X, Eichele G, Zeisberg EM, Kranz A, Stewart FA, Fischer A Journal EMBO Journal Citation EMBO J. 2022 Jan 4; 41(1): e106459. Abstract In
Learn More

Foto: © Johannes Pauly / Max-Planck-Institut für Multidisziplinäre Naturwissenschaften

03.01.2022

Neues Max-Planck-Institut in Göttingen verbindet Natur- und Medizinwissenschaften

Die Göttinger Max-Planck-Institute (MPI) für biophysikalische Chemie und für Experimentelle Medizin haben zum 1. Januar 2022 fusioniert. So entsteht ein neues MPI, das Max-Planck-Institut für Multidisziplinäre Naturwissenschaften. Es wird ein deutlich breiteres Forschungsspektrum abdecken und so die disziplinäre Vielfalt und Zusammenarbeit fördern. Mit insgesamt 16 Abteilungen und über 25 Forschungsgruppen
Learn More
X

Open Positions

EN DE
X
X